CARL ZEISS MEDITEC ADR 1 - Asset Resilience Ratio

Latest as of March 2025: 0.72%

CARL ZEISS MEDITEC ADR 1 (AFXA) has an Asset Resilience Ratio of 0.72% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€24.90 Million
≈ $29.11 Million USD Cash + Short-term Investments

Total Assets

€3.47 Billion
≈ $4.06 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how CARL ZEISS MEDITEC ADR 1's Asset Resilience Ratio has changed over time. See CARL ZEISS MEDITEC ADR 1 leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down CARL ZEISS MEDITEC ADR 1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CARL ZEISS MEDITEC ADR 1 market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €24.90 Million 0.72%
Total Liquid Assets €24.90 Million 0.72%

Asset Resilience Insights

  • Limited Liquidity: CARL ZEISS MEDITEC ADR 1 maintains only 0.72% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

CARL ZEISS MEDITEC ADR 1 Industry Peers by Asset Resilience Ratio

Compare CARL ZEISS MEDITEC ADR 1's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Autek China Inc
SHE:300595
Medical Instruments & Supplies 21.20%
QITIAN Technology Group Co Ltd
SHE:300061
Medical Instruments & Supplies 0.00%
Caina Technology Co. Ltd.
SHE:301122
Medical Instruments & Supplies 19.74%
Visco Vision Inc.
TW:6782
Medical Instruments & Supplies 0.98%
Guangzhou Jet Bio-Filtration Co Ltd
SHG:688026
Medical Instruments & Supplies 8.17%
Medeon Biodesign
TWO:6499
Medical Instruments & Supplies 7.38%
Interojo Inc
KQ:119610
Medical Instruments & Supplies 6.55%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%

Annual Asset Resilience Ratio for CARL ZEISS MEDITEC ADR 1 (None–None)

The table below shows the annual Asset Resilience Ratio data for CARL ZEISS MEDITEC ADR 1.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points

About CARL ZEISS MEDITEC ADR 1

F:AFXA Germany Medical Instruments & Supplies
Market Cap
$2.72 Billion
€2.33 Billion EUR
Market Cap Rank
#5946 Global
#911 in Germany
Share Price
€26.60
Change (1 day)
-1.48%
52-Week Range
€22.40 - €65.00
All Time High
€194.84
About

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for ret… Read more